News
-
-
PRESS RELEASE
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
MIRA Pharmaceuticals advances Ketamir-2 in clinical trials for neuropathic pain and expands into neuropsychiatric disorders like PTSD, showing promising results in a PTSD model -
-
-
-
-
-
-
-
PRESS RELEASE
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
Moderna reports 8-fold increase in neutralizing antibodies with Spikevax 2025-2026 formula, reinforcing FDA approval. Clinical trial data supports efficacy against COVID-19 LP.8.1 variant